Cipla
Cipla Limited (stylized as Cipla) is an Indian multinational pharmaceutical company, headquartered in Mumbai, India. Cipla primarily develops medicines to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression and many other medical conditions.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Abacavir | Abacavir | 2017-11-21 | 2027-2029 | |
| Abacavir lamivudine | Abacavir, Lamivudine | 2017-03-28 | 2027-2036 | |
| Acyclovir | Acyclovir | 2019-01-18 | 2027-2030 | |
| Albendazole | Albendazole | 2018-09-21 | ||
| Albuterol | Albuterol | 2020-04-08 | 2024-2041 | |
| Albuterol ipratropium | Albuterol, Ipratropium | 2007-12-31 | 2024-2041 | |
| Alendronate | Alendronate | 2008-08-04 | 2031 | |
| Alfuzosin | Alfuzosin | 2012-01-17 | ||
| Amantadine | Amantadine | 2016-09-30 | 2025-2038 | |
| Ambrisentan | Ambrisentan | 2019-04-26 | 2027-2031 | |
| Amlodipine besylate | Amlodipine besylate | 2007-09-26 | — | |
| Amlodipine besylate benazepril | Amlodipine besylate, Benazepril | 2018-12-07 |
1
2
3
4
5
6
...
11
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use